A greater proportion of younger patients ( 50 years ) on ERT ( n = 18 ) had stable WML burden compared with younger patients in the placebo group ( n = 13 ) : 44 % ( 8 of 18 ) versus 31 % ( 4 of 13 ) , p = 0.014 .